BALOXAVIR MARBOXIL

BALOXAVIR MARBOXIL was reported 2319 times

BALOXAVIR MARBOXIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROGRESSIVE MACULAR HYPOMELANOSIS 2 0.4000
1 HAEMORRHAGIC GASTROENTERITIS 1 0.2000
2 PERINEAL OEDEMA 1 0.2000
3 RETICULOCYTE PERCENTAGE ABNORMAL 1 0.1000
4 ANTIVIRAL PROPHYLAXIS 1 0.0909
5 DELIRIUM FEBRILE 8 0.0769
6 MEDICATION CRYSTALS IN URINE PRESENT 1 0.0714
7 ACUTE ENCEPHALITIS WITH REFRACTORY, REPETITIVE PARTIAL SEIZURES 1 0.0714
8 ENCEPHALITIS INFLUENZAL 1 0.0667
9 TROPONIN I 1 0.0667
10 MENARCHE 1 0.0526
11 PORTAL VEIN FLOW DECREASED 1 0.0244
12 CERULOPLASMIN DECREASED 1 0.0233
13 GASTRIC DYSPLASIA 1 0.0213
14 STRAWBERRY TONGUE 1 0.0189
15 INFLUENZA B VIRUS TEST POSITIVE 3 0.0165
16 VULVOVAGINAL DISORDER 1 0.0164
17 ELECTROCARDIOGRAM U WAVE PRESENT 1 0.0161
18 HYPERPYREXIA 68 0.0160
19 VIRAL MYELITIS 1 0.0145
20 OROPHARYNGEAL ERYTHEMA 2 0.0137
21 ENCEPHALITIS TOXIC 1 0.0127
22 PNEUMONIA INFLUENZAL 12 0.0101
23 PHARYNGEAL STENOSIS 1 0.0097
24 COLITIS ISCHAEMIC 57 0.0084
25 BILIRUBIN URINE PRESENT 1 0.0084
26 PARANASAL SINUS MUCOSAL HYPERTROPHY 1 0.0084
27 LARYNGEAL NEOPLASM 1 0.0082
28 CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME 1 0.0081
29 BLOOD LACTIC ACID 1 0.0078
30 NASAL FLARING 1 0.0074
31 SERUM AMYLOID A PROTEIN INCREASED 1 0.0065
32 UROBILINOGEN URINE INCREASED 1 0.0061
33 LARYNGEAL INJURY 1 0.0058
34 ACUTE CARDIAC EVENT 1 0.0058
35 ANTISYNTHETASE SYNDROME 1 0.0056
36 ACINETOBACTER TEST POSITIVE 1 0.0052
37 HERPES DERMATITIS 1 0.0050
38 ENTEROCOLITIS HAEMORRHAGIC 7 0.0047
39 INFLUENZA A VIRUS TEST POSITIVE 2 0.0046
40 COLORECTAL ADENOCARCINOMA 1 0.0045
41 LARYNX IRRITATION 1 0.0043
42 URINARY OCCULT BLOOD POSITIVE 1 0.0043
43 PERIPHERAL VEIN THROMBOSIS 1 0.0042
44 CALCIUM IONISED DECREASED 1 0.0041
45 FEBRILE CONVULSION 5 0.0041
46 TRI-IODOTHYRONINE FREE DECREASED 1 0.0039
47 PRODUCT BLISTER PACKAGING ISSUE 4 0.0038
48 DISORGANISED SPEECH 7 0.0038
49 SYRINGOMYELIA 1 0.0036
50 LOWER RESPIRATORY TRACT CONGESTION 6 0.0035
51 VULVAL ULCERATION 1 0.0035
52 HEPATITIS B SURFACE ANTIBODY POSITIVE 1 0.0034
53 LITHIASIS 1 0.0033
54 ENTEROCOLITIS VIRAL 1 0.0033
55 BLOOD BETA-D-GLUCAN INCREASED 1 0.0033
56 ASPERGILLUS TEST POSITIVE 1 0.0032
57 INTENTIONAL PRODUCT USE ISSUE 283 0.0032
58 MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0032
59 TOXIC SHOCK SYNDROME 2 0.0032
60 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 19 0.0031
61 EYE INFECTION VIRAL 1 0.0031
62 NO ADVERSE EVENT 547 0.0030
63 ACUTE DISSEMINATED ENCEPHALOMYELITIS 1 0.0029
64 ORAL DISCHARGE 1 0.0027
65 SHOCK SYMPTOM 1 0.0027
66 HUMORAL IMMUNE DEFECT 1 0.0027
67 PROCALCITONIN INCREASED 3 0.0026
68 LARYNGEAL PAIN 1 0.0025
69 ENCEPHALITIS VIRAL 3 0.0025
70 OCULOMUCOCUTANEOUS SYNDROME 1 0.0024
71 POSTRENAL FAILURE 1 0.0023
72 GALLBLADDER RUPTURE 1 0.0022
73 TONIC CONVULSION 3 0.0021
74 HYPOPROTEINAEMIA 4 0.0021
75 OESOPHAGEAL ADENOCARCINOMA 1 0.0021
76 BLOOD BICARBONATE INCREASED 1 0.0021
77 PNEUMONIA BACTERIAL 19 0.0021
78 BLOOD URIC ACID DECREASED 1 0.0021
79 DROWNING 2 0.0020
80 PO2 INCREASED 1 0.0020
81 SUPRAPUBIC PAIN 1 0.0020
82 GLARE 1 0.0019
83 COGWHEEL RIGIDITY 2 0.0019
84 PHARYNGEAL MASS 1 0.0019
85 MYOGLOBINURIA 1 0.0019
86 GALLBLADDER ENLARGEMENT 2 0.0019
87 BLOOD GASES ABNORMAL 1 0.0019
88 ERYTHEMA MULTIFORME 17 0.0018
89 UTERINE CYST 1 0.0018
90 BLOOD FIBRINOGEN DECREASED 2 0.0018
91 ENANTHEMA 1 0.0017
92 FLASHBACK 1 0.0017
93 PNEUMOCOCCAL INFECTION 1 0.0017
94 THYROXINE DECREASED 1 0.0016
95 PNEUMONIA VIRAL 5 0.0016
96 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
97 PNEUMONIA NECROTISING 1 0.0015
98 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 1 0.0015
99 KLEBSIELLA TEST POSITIVE 1 0.0015
100 C-REACTIVE PROTEIN DECREASED 1 0.0015
101 PNEUMOCOCCAL SEPSIS 1 0.0015
102 BONE DEFORMITY 1 0.0015
103 CYTOKINE STORM 1 0.0015
104 CRANIAL NERVE DISORDER 1 0.0014
105 HAEMORRHAGIC CEREBRAL INFARCTION 1 0.0014
106 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0014
107 PELVIC FLUID COLLECTION 1 0.0014
108 ELECTROCARDIOGRAM ST-T CHANGE 1 0.0014
109 MONOCYTE PERCENTAGE INCREASED 1 0.0014
110 ALPHA 1 FOETOPROTEIN INCREASED 1 0.0014
111 GASTRIC MUCOSAL LESION 1 0.0014
112 DYSPNOEA PAROXYSMAL NOCTURNAL 1 0.0014
113 CLONIC CONVULSION 1 0.0014
114 MELAENA 30 0.0014
115 BRAIN HERNIATION 4 0.0013
116 MARASMUS 2 0.0013
117 COAGULATION TIME PROLONGED 2 0.0013
118 BREAST FEEDING 1 0.0013
119 MYCOPLASMA INFECTION 1 0.0013
120 CROUP INFECTIOUS 1 0.0013
121 LACUNAR INFARCTION 3 0.0013
122 LIP ERYTHEMA 1 0.0013
123 HEPATITIS VIRAL 1 0.0012
124 IIIRD NERVE PARALYSIS 1 0.0012
125 DYSBIOSIS 1 0.0012
126 IGA NEPHROPATHY 2 0.0012
127 VULVOVAGINAL ERYTHEMA 1 0.0012
128 HEPATITIS A 1 0.0012
129 THALAMUS HAEMORRHAGE 1 0.0011
130 DRUG ERUPTION 20 0.0011
131 INTERCEPTED PRODUCT STORAGE ERROR 4 0.0011
132 PARVOVIRUS B19 INFECTION 1 0.0011
133 ADENOCARCINOMA GASTRIC 1 0.0011
134 MECHANICAL VENTILATION 2 0.0011
135 ENTEROCOLITIS 6 0.0010
136 MOTION SICKNESS 2 0.0010
137 MASTOIDITIS 1 0.0010
138 HYPERAEMIA 2 0.0010
139 PNEUMONIA STAPHYLOCOCCAL 2 0.0010
140 ULNA FRACTURE 1 0.0010
141 SPUTUM RETENTION 1 0.0010
142 CYSTITIS HAEMORRHAGIC 4 0.0010
143 ILEAL ULCER 1 0.0010
144 CHEST X-RAY ABNORMAL 3 0.0010
145 CORONAVIRUS TEST POSITIVE 1 0.0010
146 AMAUROSIS FUGAX 1 0.0009
147 BONE NEOPLASM 1 0.0009
148 ALTERED STATE OF CONSCIOUSNESS 20 0.0009
149 HAEMORRHAGIC DISORDER 1 0.0009
150 PRESCRIBED UNDERDOSE 18 0.0009
151 FACIAL SPASM 1 0.0009
152 GASTROINTESTINAL ULCER HAEMORRHAGE 1 0.0009
153 PALMAR ERYTHEMA 1 0.0009
154 FEBRILE INFECTION 1 0.0008
155 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
156 HAEMORRHAGIC DIATHESIS 3 0.0008
157 BILE DUCT CANCER 1 0.0008
158 CARDIAC DEATH 1 0.0008
159 EYELID SKIN DRYNESS 1 0.0008
160 BLOOD UREA DECREASED 1 0.0008
161 NEUTROPHIL PERCENTAGE INCREASED 1 0.0008
162 LIP DISCOLOURATION 1 0.0008
163 HYPERAESTHESIA TEETH 1 0.0008
164 ABORTION MISSED 1 0.0008
165 GLUCOSE URINE PRESENT 1 0.0008
166 ANAPHYLACTIC SHOCK 20 0.0008
167 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
168 BILIARY OBSTRUCTION 1 0.0008
169 POSTMENOPAUSAL HAEMORRHAGE 2 0.0008
170 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
171 ABNORMAL BEHAVIOUR 30 0.0008
172 GASTROENTERITIS NOROVIRUS 1 0.0008
173 EFFUSION 1 0.0007
174 ANAPHYLACTOID REACTION 3 0.0007
175 HEAD TITUBATION 1 0.0007
176 ANAPHYLACTIC REACTION 40 0.0007
177 MACULE 2 0.0007
178 ENDOTRACHEAL INTUBATION 2 0.0007
179 PSYCHOMOTOR RETARDATION 2 0.0007
180 UPPER RESPIRATORY TRACT CONGESTION 2 0.0007
181 ILEUS PARALYTIC 3 0.0007
182 STEROID DIABETES 1 0.0007
183 MYOGLOBIN BLOOD INCREASED 1 0.0007
184 INTERCEPTED MEDICATION ERROR 3 0.0006
185 MYELITIS 1 0.0006
186 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
187 SWELLING OF EYELID 4 0.0006
188 URINE KETONE BODY PRESENT 1 0.0006
189 DELIRIUM 22 0.0006
190 PHARYNGEAL PARAESTHESIA 1 0.0006
191 RHABDOMYOLYSIS 26 0.0006
192 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
193 HEPATIC FUNCTION ABNORMAL 23 0.0006
194 LISTLESS 2 0.0006
195 ANTIBODY TEST POSITIVE 1 0.0006
196 TROPONIN I INCREASED 1 0.0006
197 HEPATORENAL SYNDROME 1 0.0006
198 HEPATIC CYST 2 0.0006
199 ENTERITIS INFECTIOUS 1 0.0006
200 CERVICAL VERTEBRAL FRACTURE 2 0.0006
201 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
202 SPINAL CORD INJURY 1 0.0006
203 EXTREMITY NECROSIS 1 0.0006
204 GLOSSITIS 2 0.0006
205 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
206 LIVER TRANSPLANT REJECTION 1 0.0006
207 FAECES SOFT 4 0.0005
208 PUPILLARY REFLEX IMPAIRED 1 0.0005
209 INFLUENZA 60 0.0005
210 FACE OEDEMA 9 0.0005
211 NASAL OBSTRUCTION 1 0.0005
212 CONVERSION DISORDER 1 0.0005
213 ABDOMINAL WALL HAEMATOMA 1 0.0005
214 PROTHROMBIN TIME PROLONGED 3 0.0005
215 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
216 SMALL INTESTINAL HAEMORRHAGE 1 0.0005
217 FOAMING AT MOUTH 1 0.0005
218 EAR HAEMORRHAGE 1 0.0005
219 FEEDING DISORDER 10 0.0005
220 EYELID PAIN 1 0.0005
221 RENAL HAEMORRHAGE 1 0.0005
222 ENCEPHALOPATHY 12 0.0005
223 OFF LABEL USE 427 0.0005
224 QUADRIPLEGIA 1 0.0005
225 LIP OEDEMA 2 0.0005
226 FACIAL PARALYSIS 4 0.0005
227 LANGUAGE DISORDER 1 0.0005
228 PRODUCT PRESCRIBING ERROR 11 0.0005
229 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
230 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
231 PARESIS 1 0.0004
232 LIVER INJURY 11 0.0004
233 PRODUCT ADMINISTRATION ERROR 9 0.0004
234 HAEMATOCHEZIA 24 0.0004
235 NEPHROGENIC ANAEMIA 2 0.0004
236 DEPRESSED LEVEL OF CONSCIOUSNESS 17 0.0004
237 MENOPAUSAL SYMPTOMS 1 0.0004
238 SINUS PAIN 1 0.0004
239 DIARRHOEA HAEMORRHAGIC 4 0.0004
240 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
241 CARDIAC TAMPONADE 2 0.0004
242 EOSINOPHIL COUNT DECREASED 1 0.0004
243 RADIUS FRACTURE 1 0.0004
244 PAINFUL RESPIRATION 1 0.0004
245 STARING 1 0.0004
246 GUILLAIN-BARRE SYNDROME 2 0.0004
247 MOUTH HAEMORRHAGE 3 0.0004
248 HYPERNATRAEMIA 2 0.0004
249 TACHYARRHYTHMIA 1 0.0004
250 HALLUCINATION 30 0.0004
251 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
252 ANGLE CLOSURE GLAUCOMA 1 0.0004
253 SHOCK 9 0.0004
254 INCREASED BRONCHIAL SECRETION 1 0.0004
255 PRODUCT TEMPERATURE EXCURSION ISSUE 2 0.0004
256 PHYSICAL DECONDITIONING 1 0.0004
257 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
258 COMPARTMENT SYNDROME 1 0.0004
259 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
260 CYANOSIS 6 0.0004
261 PRODUCT USE COMPLAINT 6 0.0004
262 HAEMATURIA 13 0.0004
263 LUNG OPACITY 1 0.0004
264 STEATORRHOEA 1 0.0004
265 PRODUCT DISPENSING ERROR 8 0.0004
266 LIP BLISTER 1 0.0004
267 BRONCHITIS 27 0.0004
268 LUNG CONSOLIDATION 1 0.0004
269 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
270 PNEUMONIA 115 0.0004
271 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
272 GENERALISED ERYTHEMA 2 0.0004
273 RESPIRATORY SYMPTOM 1 0.0004
274 VITAMIN B12 DECREASED 1 0.0003
275 BLOOD URIC ACID INCREASED 2 0.0003
276 HYPERTONIC BLADDER 1 0.0003
277 LOSS OF CONSCIOUSNESS 44 0.0003
278 ABORTION 1 0.0003
279 STRIDOR 1 0.0003
280 URINE ANALYSIS ABNORMAL 1 0.0003
281 METABOLIC ENCEPHALOPATHY 1 0.0003
282 HYPERCAPNIA 1 0.0003
283 PATHOGEN RESISTANCE 3 0.0003
284 VULVOVAGINAL BURNING SENSATION 2 0.0003
285 LARYNGEAL OEDEMA 2 0.0003
286 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
287 OLIGURIA 2 0.0003
288 BACTERIAL INFECTION 6 0.0003
289 BLOOD CREATININE DECREASED 1 0.0003
290 DERMATITIS ALLERGIC 4 0.0003
291 EOSINOPHILIC PNEUMONIA 1 0.0003
292 NON-CARDIAC CHEST PAIN 1 0.0003
293 BILE DUCT STONE 1 0.0003
294 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
295 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
296 LIP SWELLING 10 0.0003
297 WRONG PRODUCT ADMINISTERED 2 0.0003
298 B-CELL LYMPHOMA 1 0.0003
299 EPISTAXIS 22 0.0003
300 BODY TEMPERATURE INCREASED 6 0.0003
301 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
302 REGURGITATION 1 0.0003
303 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
304 HYPOPNOEA 1 0.0003
305 MEDICATION ERROR 16 0.0003
306 DRUG-INDUCED LIVER INJURY 9 0.0003
307 EMBOLIC STROKE 1 0.0003
308 LOGORRHOEA 1 0.0003
309 JAUNDICE CHOLESTATIC 1 0.0003
310 FIBRIN D DIMER INCREASED 1 0.0003
311 VOMITING 132 0.0003
312 CONJUNCTIVAL HYPERAEMIA 1 0.0003
313 CUTANEOUS VASCULITIS 1 0.0003
314 BLOOD PHOSPHORUS DECREASED 1 0.0003
315 RECTAL DISCHARGE 1 0.0003
316 PSYCHIATRIC SYMPTOM 2 0.0003
317 URINARY RETENTION 9 0.0003
318 URTICARIA 45 0.0003
319 SEIZURE 31 0.0003
320 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
321 CHROMATURIA 6 0.0003
322 PARANASAL SINUS DISCOMFORT 1 0.0003
323 PRODUCT STORAGE ISSUE 1 0.0003
324 INTERNAL HAEMORRHAGE 3 0.0003
325 HAEMODYNAMIC INSTABILITY 2 0.0003
326 PARANASAL SINUS HYPERSECRETION 1 0.0003
327 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
328 COMMUNICATION DISORDER 1 0.0003
329 OESOPHAGEAL ULCER 1 0.0003
330 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
331 FAECES HARD 1 0.0003
332 EPIGASTRIC DISCOMFORT 1 0.0003
333 ORAL INFECTION 1 0.0003
334 EXPOSURE VIA BREAST MILK 1 0.0003
335 CEREBRAL ATROPHY 1 0.0003
336 BLEPHARITIS 1 0.0002
337 MUSCLE HAEMORRHAGE 1 0.0002
338 GALLBLADDER OPERATION 1 0.0002
339 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
340 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
341 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
342 AORTIC DISSECTION 1 0.0002
343 GASTROINTESTINAL PERFORATION 1 0.0002
344 INTENTIONAL PRODUCT MISUSE 21 0.0002
345 SLEEP TERROR 1 0.0002
346 HAEMATEMESIS 6 0.0002
347 CIRCULATORY COLLAPSE 4 0.0002
348 UTERINE HAEMORRHAGE 1 0.0002
349 ANURIA 2 0.0002
350 OCULAR ICTERUS 1 0.0002
351 CHAPPED LIPS 1 0.0002
352 GINGIVAL SWELLING 1 0.0002
353 VULVOVAGINAL DISCOMFORT 1 0.0002
354 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
355 MYOSITIS 2 0.0002
356 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
357 C-REACTIVE PROTEIN INCREASED 8 0.0002
358 IMMUNE THROMBOCYTOPENIA 1 0.0002
359 LUMBAR VERTEBRAL FRACTURE 1 0.0002
360 LOCALISED OEDEMA 1 0.0002
361 AGRANULOCYTOSIS 4 0.0002
362 HAEMOPTYSIS 6 0.0002
363 MASS 3 0.0002
364 HEPATIC ENCEPHALOPATHY 2 0.0002
365 NEPHROPATHY 2 0.0002
366 YELLOW SKIN 1 0.0002
367 SKIN TIGHTNESS 1 0.0002
368 SINUS TACHYCARDIA 3 0.0002
369 BLOOD PRESSURE DECREASED 14 0.0002
370 DIARRHOEA 136 0.0002
371 PRODUCT PACKAGING ISSUE 2 0.0002
372 HYPOVOLAEMIC SHOCK 1 0.0002
373 ACUTE RESPIRATORY FAILURE 4 0.0002
374 PRESCRIBED OVERDOSE 4 0.0002
375 GASTROENTERITIS 3 0.0002
376 HORMONE LEVEL ABNORMAL 1 0.0002
377 ORAL HERPES 4 0.0002
378 RENAL TUBULAR NECROSIS 2 0.0002
379 VITREOUS FLOATERS 2 0.0002
380 BREATH SOUNDS ABNORMAL 1 0.0002
381 INFLAMMATORY MARKER INCREASED 1 0.0002
382 PROTEIN URINE PRESENT 1 0.0002
383 HEPATIC ENZYME ABNORMAL 1 0.0002
384 HYPERAMMONAEMIA 1 0.0002
385 PREGNANCY 4 0.0002
386 TOXIC SKIN ERUPTION 2 0.0002
387 DYSPHORIA 1 0.0002
388 HYPOTHERMIA 2 0.0002
389 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
390 VULVOVAGINAL PRURITUS 1 0.0002
391 DRY THROAT 2 0.0002
392 CEREBRAL ISCHAEMIA 1 0.0002
393 PETECHIAE 2 0.0002
394 TONSILLITIS 1 0.0002
395 CARDIO-RESPIRATORY ARREST 8 0.0002
396 BLOOD LACTIC ACID INCREASED 1 0.0002
397 SERUM FERRITIN INCREASED 1 0.0002
398 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
399 SUDDEN DEATH 2 0.0002
400 NYSTAGMUS 1 0.0002
401 EYE SWELLING 7 0.0002
402 ANORECTAL DISCOMFORT 1 0.0002
403 RETCHING 4 0.0002
404 SENSORY DISTURBANCE 3 0.0002
405 FOOD POISONING 1 0.0002
406 JAUNDICE 5 0.0002
407 BEHAVIOUR DISORDER 1 0.0002
408 ERYTHEMA OF EYELID 1 0.0002
409 ILLNESS 19 0.0002
410 VENTRICULAR TACHYCARDIA 3 0.0002
411 DEAFNESS UNILATERAL 1 0.0002
412 COAGULOPATHY 3 0.0002
413 STREPTOCOCCAL INFECTION 1 0.0002
414 INTERMENSTRUAL BLEEDING 1 0.0002
415 ANGIOPATHY 1 0.0002
416 BLOOD CALCIUM DECREASED 2 0.0002
417 CHOLECYSTITIS ACUTE 1 0.0002
418 NEUROLOGICAL SYMPTOM 1 0.0002
419 MYOCARDITIS 2 0.0002
420 MOUTH SWELLING 1 0.0002
421 RALES 1 0.0002
422 EYELID OEDEMA 2 0.0002
423 SKIN WARM 1 0.0002
424 HYPOXIA 6 0.0002
425 HYPERCHLORHYDRIA 1 0.0002
426 SYNCOPE 17 0.0002
427 LYMPHOCYTE COUNT DECREASED 3 0.0002
428 BRADYKINESIA 1 0.0002
429 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
430 BACTERAEMIA 2 0.0002
431 PLEURISY 1 0.0002
432 CHOLECYSTITIS 2 0.0002
433 CARDIAC PACEMAKER INSERTION 1 0.0002
434 HEPATITIS CHOLESTATIC 1 0.0002
435 INTERSTITIAL LUNG DISEASE 8 0.0002
436 DEHYDRATION 22 0.0002
437 RESPIRATORY FAILURE 12 0.0002
438 CEREBRAL INFARCTION 4 0.0002
439 CHOLANGITIS 1 0.0002
440 RASH 70 0.0002
441 COUGH 45 0.0002
442 PYREXIA 55 0.0002
443 COLITIS 6 0.0002
444 SCREAMING 1 0.0002
445 HYPOPHAGIA 4 0.0002
446 HEPATITIS 4 0.0002
447 ENTERITIS 1 0.0002
448 MYDRIASIS 2 0.0002
449 DRUG RESISTANCE 4 0.0002
450 GENITAL HAEMORRHAGE 2 0.0002
451 HEPATITIS ACUTE 1 0.0002
452 HERPES SIMPLEX 1 0.0002
453 NASAL CONGESTION 9 0.0002
454 BRADYPHRENIA 1 0.0002
455 ASPERGILLUS INFECTION 1 0.0002
456 SOMNAMBULISM 1 0.0002
457 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
458 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
459 EAR INFECTION 4 0.0002
460 CARDIAC FAILURE ACUTE 1 0.0001
461 EYE HAEMORRHAGE 2 0.0001
462 MENINGITIS 1 0.0001
463 CHOLECYSTITIS CHRONIC 1 0.0001
464 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
465 PRODUCT USE ISSUE 28 0.0001
466 EXTRA DOSE ADMINISTERED 6 0.0001
467 THROAT TIGHTNESS 4 0.0001
468 PRODUCT LABEL ISSUE 1 0.0001
469 NEUTROPHIL COUNT DECREASED 6 0.0001
470 TACHYPNOEA 2 0.0001
471 PALLOR 4 0.0001
472 PNEUMONITIS 4 0.0001
473 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
474 SINUSITIS 15 0.0001
475 ACUTE HEPATIC FAILURE 2 0.0001
476 ECCHYMOSIS 1 0.0001
477 ABNORMAL DREAMS 4 0.0001
478 ENCEPHALITIS 1 0.0001
479 FORMICATION 1 0.0001
480 PAPULE 1 0.0001
481 LYMPHOPENIA 2 0.0001
482 PARALYSIS 2 0.0001
483 FAECES DISCOLOURED 3 0.0001
484 DERMATITIS BULLOUS 1 0.0001
485 MENTAL DISORDER 6 0.0001
486 BLOOD CREATININE INCREASED 9 0.0001
487 ORAL DISORDER 1 0.0001
488 STEVENS-JOHNSON SYNDROME 3 0.0001
489 ABDOMINAL PAIN 31 0.0001
490 HYPOAESTHESIA ORAL 2 0.0001
491 TINNITUS 6 0.0001
492 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
493 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
494 WHITE BLOOD CELL COUNT DECREASED 14 0.0001
495 HYPOALBUMINAEMIA 1 0.0001
496 GASTROINTESTINAL INFLAMMATION 1 0.0001
497 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
498 BLOOD ALBUMIN DECREASED 1 0.0001
499 RENAL CYST 1 0.0001
500 HALLUCINATION, AUDITORY 2 0.0001
501 GINGIVAL PAIN 1 0.0001
502 SEPSIS 14 0.0001
503 BLISTER 7 0.0001
504 MIOSIS 1 0.0001
505 SENSORY LOSS 1 0.0001
506 ACUTE KIDNEY INJURY 19 0.0001
507 FRUSTRATION TOLERANCE DECREASED 1 0.0001
508 MUSCLE DISORDER 1 0.0001
509 PLATELET COUNT DECREASED 13 0.0001
510 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
511 EMBOLISM 1 0.0001
512 EXPIRED PRODUCT ADMINISTERED 4 0.0001
513 EOSINOPHIL COUNT INCREASED 1 0.0001
514 BLOOD UREA INCREASED 2 0.0001
515 SENSATION OF FOREIGN BODY 1 0.0001
516 DECREASED APPETITE 27 0.0001
517 BLOOD MAGNESIUM DECREASED 1 0.0001
518 MUSCLE STRAIN 1 0.0001
519 URINE OUTPUT DECREASED 1 0.0001
520 GROIN PAIN 1 0.0001
521 COLD SWEAT 2 0.0001
522 LUNG INFILTRATION 1 0.0001
523 ANGIOEDEMA 5 0.0001
524 PURPURA 1 0.0001
525 LIVER DISORDER 5 0.0001
526 RESPIRATORY RATE INCREASED 1 0.0001
527 HAEMOLYTIC ANAEMIA 1 0.0001
528 HAEMARTHROSIS 1 0.0001
529 THROAT IRRITATION 5 0.0001
530 BLOOD BILIRUBIN INCREASED 3 0.0001
531 LIP DRY 1 0.0001
532 ACCIDENTAL OVERDOSE 4 0.0001
533 RESTLESSNESS 4 0.0001
534 RESPIRATORY ARREST 3 0.0001
535 CONJUNCTIVITIS 2 0.0001
536 PERSONALITY CHANGE 1 0.0001
537 CHEST DISCOMFORT 11 0.0001
538 THINKING ABNORMAL 2 0.0001
539 PRODUCT DOSE OMISSION 7 0.0001
540 APPENDICITIS 1 0.0001
541 FLANK PAIN 1 0.0001
542 HYPOCALCAEMIA 2 0.0001
543 ARRHYTHMIA 5 0.0001
544 EYE INFLAMMATION 1 0.0001
545 AFFECT LABILITY 1 0.0001
546 EAR PAIN 2 0.0001
547 AUTOIMMUNE DISORDER 1 0.0001
548 VITAMIN D DEFICIENCY 1 0.0001
549 PHARYNGEAL SWELLING 1 0.0001
550 HEADACHE 64 0.0001
551 ABORTION SPONTANEOUS 4 0.0001
552 BLOOD POTASSIUM DECREASED 3 0.0001
553 HEPATIC FAILURE 3 0.0001
554 PRODUCT PHYSICAL ISSUE 2 0.0001
555 TASTE DISORDER 2 0.0001
556 DYSKINESIA 4 0.0001
557 EYELID PTOSIS 1 0.0001
558 MOTOR DYSFUNCTION 1 0.0001
559 EUPHORIC MOOD 1 0.0001
560 HYPERBILIRUBINAEMIA 1 0.0001
561 INCORRECT DOSE ADMINISTERED 22 0.0001
562 NERVOUS SYSTEM DISORDER 3 0.0001
563 SWOLLEN TONGUE 3 0.0001
564 TENDERNESS 1 0.0001
565 ECZEMA 5 0.0001
566 RENAL IMPAIRMENT 8 0.0001
567 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
568 NAUSEA 75 0.0001
569 HALLUCINATION, VISUAL 2 0.0001
570 INCONTINENCE 1 0.0001
571 DYSGEUSIA 7 0.0001
572 EATING DISORDER 2 0.0001
573 METABOLIC ACIDOSIS 3 0.0001
574 MALAISE 41 0.0001
575 HEREDITARY ANGIOEDEMA 1 0.0001
576 RASH PRURITIC 5 0.0001
577 OEDEMA 5 0.0001
578 SWELLING FACE 6 0.0001
579 ASPIRATION 1 0.0001
580 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
581 VIRAL INFECTION 3 0.0001
582 GAIT INABILITY 3 0.0001
583 MALNUTRITION 1 0.0001
584 DIZZINESS 44 0.0001
585 NIGHTMARE 3 0.0001
586 ELECTROLYTE IMBALANCE 1 0.0001
587 VASCULITIS 1 0.0001
588 HYPERKALAEMIA 3 0.0001
589 DYSPHONIA 5 0.0001
590 SPLENOMEGALY 1 0.0001
591 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
592 HYPERLIPIDAEMIA 1 0.0001
593 CRYING 3 0.0001
594 CYTOPENIA 1 0.0001
595 LUNG DISORDER 4 0.0001
596 RESPIRATORY DEPRESSION 1 0.0001
597 DYSURIA 3 0.0001
598 HEART RATE INCREASED 8 0.0001
599 MUSCLE ATROPHY 1 0.0001
600 PRODUCT COMPLAINT 2 0.0001
601 INTRAOCULAR PRESSURE INCREASED 1 0.0001
602 ABDOMINAL DISCOMFORT 13 0.0001
603 RHINORRHOEA 5 0.0001
604 RASH GENERALISED 2 0.0001
605 RESPIRATORY TRACT INFECTION 2 0.0001
606 PLATELET COUNT INCREASED 1 0.0001
607 DEAFNESS 2 0.0001
608 DISORIENTATION 3 0.0001
609 HYPERSENSITIVITY 14 0.0001
610 PRODUCT DOSE OMISSION ISSUE 22 0.0001
611 CARDIAC FAILURE 6 0.0001
612 SINUS CONGESTION 1 0.0001
613 MENTAL STATUS CHANGES 2 0.0001
614 ORAL DISCOMFORT 1 0.0001
615 POLLAKIURIA 3 0.0001
616 ATRIAL FIBRILLATION 7 0.0001
617 HYPOMAGNESAEMIA 1 0.0001
618 HUNGER 1 0.0001
619 COORDINATION ABNORMAL 1 0.0001
620 DEMENTIA 2 0.0001
621 HYPONATRAEMIA 4 0.0001
622 SKIN REACTION 1 0.0001
623 CARDIOGENIC SHOCK 1 0.0001
624 PARAESTHESIA ORAL 1 0.0001
625 ASTHENIA 26 0.0001
626 SEPTIC SHOCK 3 0.0001
627 UNDERDOSE 5 0.0001
628 DYSSTASIA 2 0.0001
629 DRUG INEFFECTIVE 90 0.0001
630 CONFUSIONAL STATE 11 0.0001
631 PRURITUS 26 0.0001
632 URINARY INCONTINENCE 2 0.0001
633 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
634 PULMONARY OEDEMA 3 0.0001
635 RESPIRATORY DISORDER 2 0.0001
636 HYPOAESTHESIA 10 0.0001
637 APHASIA 2 0.0001
638 LACRIMATION INCREASED 2 0.0001
639 OSTEOPENIA 1 0.0001
640 ILL-DEFINED DISORDER 4 0.0001
641 VERTIGO 4 0.0001
642 EPILEPSY 2 0.0001
643 MUSCLE SPASMS 12 0.0001
644 SKIN DISCOLOURATION 3 0.0001
645 OROPHARYNGEAL PAIN 6 0.0001
646 LYMPHOMA 1 0.0001
647 LIMB DISCOMFORT 2 0.0001
648 EJECTION FRACTION DECREASED 1 0.0001
649 BRAIN FOG 1 0.0001
650 ERYTHEMA 13 0.0001
651 HYPERHIDROSIS 8 0.0001
652 HYPOGLYCAEMIA 3 0.0001
653 CHOLELITHIASIS 2 0.0001
654 MANIA 1 0.0001
655 STAPHYLOCOCCAL INFECTION 2 0.0001
656 PHOTOSENSITIVITY REACTION 1 0.0001
657 FEBRILE NEUTROPENIA 4 0.0001
658 CYTOMEGALOVIRUS INFECTION 1 0.0001
659 FUNGAL INFECTION 2 0.0001
660 LEUKOPENIA 3 0.0001
661 PERICARDITIS 1 0.0001
662 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
663 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 12 0.0001
664 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
665 METRORRHAGIA 1 0.0001
666 FEELING ABNORMAL 14 0.0001
667 DEVICE DEFECTIVE 1 0.0001
668 HAEMORRHAGE 6 0.0001
669 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
670 HEAD DISCOMFORT 1 0.0001
671 THIRST 1 0.0001
672 GOUT 1 0.0001
673 LEUKOCYTOSIS 1 0.0001
674 HEPATIC STEATOSIS 1 0.0001
675 ABDOMINAL PAIN UPPER 11 0.0001
676 DYSPNOEA EXERTIONAL 2 0.0001
677 INTESTINAL OBSTRUCTION 2 0.0001
678 BLOOD SODIUM DECREASED 1 0.0001
679 FRACTURE 1 0.0001
680 FOOT FRACTURE 1 0.0001
681 DYSPHAGIA 5 0.0001
682 GASTRIC ULCER 1 0.0001
683 PROTEINURIA 1 0.0001
684 INSOMNIA 14 0.0001
685 PULMONARY FIBROSIS 1 0.0001
686 CHOLESTASIS 1 0.0001
687 GLAUCOMA 1 0.0001
688 COVID-19 9 0.0001
689 CHOKING 1 0.0001
690 DYSPNOEA 29 0.0001
691 CHILLS 6 0.0001
692 FALL 17 0.0001
693 OVERDOSE 11 0.0001
694 WHEEZING 3 0.0001
695 UPPER LIMB FRACTURE 1 0.0001
696 CYTOKINE RELEASE SYNDROME 1 0.0000
697 STOMATITIS 3 0.0000
698 PLEURAL EFFUSION 3 0.0000
699 DRY MOUTH 4 0.0000
700 PERITONITIS 1 0.0000
701 TREMOR 8 0.0000
702 ROAD TRAFFIC ACCIDENT 2 0.0000
703 OSTEOARTHRITIS 2 0.0000
704 IMPAIRED WORK ABILITY 1 0.0000
705 LIVER FUNCTION TEST INCREASED 1 0.0000
706 POOR QUALITY SLEEP 1 0.0000
707 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
708 TRANSAMINASES INCREASED 1 0.0000
709 RASH MACULO-PAPULAR 1 0.0000
710 GLOSSODYNIA 1 0.0000
711 ORAL PAIN 1 0.0000
712 GASTROINTESTINAL DISORDER 4 0.0000
713 PANCREATITIS ACUTE 1 0.0000
714 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
715 HEART RATE IRREGULAR 1 0.0000
716 DRUG INTERACTION 7 0.0000
717 NEPHROLITHIASIS 2 0.0000
718 HYPOKALAEMIA 2 0.0000
719 RENAL DISORDER 2 0.0000
720 PALPITATIONS 5 0.0000
721 PAIN 26 0.0000
722 ANAEMIA 8 0.0000
723 PRODUCTIVE COUGH 2 0.0000
724 DIABETIC KETOACIDOSIS 1 0.0000
725 INFECTION 6 0.0000
726 MENTAL IMPAIRMENT 1 0.0000
727 NEURALGIA 1 0.0000
728 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
729 DRY EYE 2 0.0000
730 PNEUMONIA ASPIRATION 1 0.0000
731 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
732 ABDOMINAL PAIN LOWER 1 0.0000
733 GASTRIC CANCER 1 0.0000
734 CONDITION AGGRAVATED 12 0.0000
735 CARDIOVASCULAR DISORDER 1 0.0000
736 BLOOD PRESSURE INCREASED 6 0.0000
737 HAEMOGLOBIN DECREASED 4 0.0000
738 DIPLOPIA 1 0.0000
739 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
740 DEATH 33 0.0000
741 MUCOSAL INFLAMMATION 1 0.0000
742 SPEECH DISORDER 2 0.0000
743 ANHEDONIA 1 0.0000
744 DERMATITIS ATOPIC 2 0.0000
745 RENAL FAILURE 5 0.0000
746 RESPIRATORY DISTRESS 1 0.0000
747 DIVERTICULITIS 1 0.0000
748 FEELING COLD 1 0.0000
749 NECK PAIN 2 0.0000
750 THROMBOCYTOPENIA 4 0.0000
751 OXYGEN SATURATION DECREASED 2 0.0000
752 ASTHMA 4 0.0000
753 PAIN IN JAW 1 0.0000
754 FLATULENCE 2 0.0000
755 RED BLOOD CELL COUNT DECREASED 1 0.0000
756 HYPOTENSION 7 0.0000
757 HYPERSOMNIA 1 0.0000
758 MYOCARDIAL INFARCTION 6 0.0000
759 LIVER FUNCTION TEST ABNORMAL 1 0.0000
760 ASCITES 1 0.0000
761 PSYCHOTIC DISORDER 1 0.0000
762 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
763 THERAPEUTIC RESPONSE DECREASED 2 0.0000
764 FEMUR FRACTURE 1 0.0000
765 VISUAL IMPAIRMENT 4 0.0000
766 EXPOSURE DURING PREGNANCY 2 0.0000
767 SWELLING 3 0.0000
768 BONE DENSITY DECREASED 1 0.0000
769 PARAESTHESIA 5 0.0000
770 MIGRAINE 3 0.0000
771 CYSTITIS 1 0.0000
772 CONTUSION 3 0.0000
773 LACTIC ACIDOSIS 1 0.0000
774 AMNESIA 2 0.0000
775 SKIN DISORDER 1 0.0000
776 NEOPLASM MALIGNANT 2 0.0000
777 EYE PRURITUS 1 0.0000
778 VISION BLURRED 4 0.0000
779 RASH MACULAR 1 0.0000
780 BURNING SENSATION 2 0.0000
781 HEART RATE DECREASED 1 0.0000
782 LYMPHADENOPATHY 1 0.0000
783 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
784 ANXIETY 8 0.0000
785 CEREBRAL HAEMORRHAGE 1 0.0000
786 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
787 MYELOSUPPRESSION 1 0.0000
788 PANIC ATTACK 1 0.0000
789 AGITATION 2 0.0000
790 DYSARTHRIA 1 0.0000
791 MUSCULAR WEAKNESS 3 0.0000
792 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
793 PERIPHERAL SWELLING 4 0.0000
794 PLASMA CELL MYELOMA 1 0.0000
795 WEIGHT DECREASED 7 0.0000
796 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
797 SOMNOLENCE 5 0.0000
798 BLINDNESS 1 0.0000
799 INFLUENZA LIKE ILLNESS 2 0.0000
800 CARDIAC ARREST 2 0.0000
801 TREATMENT FAILURE 2 0.0000
802 RECTAL HAEMORRHAGE 1 0.0000
803 TACHYCARDIA 2 0.0000
804 COLITIS ULCERATIVE 1 0.0000
805 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
806 THERAPY NON-RESPONDER 1 0.0000
807 MEMORY IMPAIRMENT 3 0.0000
808 SKIN IRRITATION 1 0.0000
809 NASOPHARYNGITIS 4 0.0000
810 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
811 CHEST PAIN 4 0.0000
812 BACK PAIN 5 0.0000
813 BREAST CANCER 2 0.0000
814 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
815 CARDIAC DISORDER 2 0.0000
816 OCULAR HYPERAEMIA 1 0.0000
817 NEUROPATHY PERIPHERAL 2 0.0000
818 DISEASE RECURRENCE 1 0.0000
819 RASH ERYTHEMATOUS 1 0.0000
820 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
821 AGGRESSION 1 0.0000
822 CELLULITIS 1 0.0000
823 FLUSHING 2 0.0000
824 THERAPY CESSATION 1 0.0000
825 INFLAMMATION 1 0.0000
826 ABDOMINAL DISTENSION 2 0.0000
827 PANCREATITIS 1 0.0000
828 DEPRESSED MOOD 1 0.0000
829 HYPERTENSION 4 0.0000
830 BRADYCARDIA 1 0.0000
831 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
832 ARTHROPATHY 1 0.0000
833 EYE PAIN 1 0.0000
834 DEPRESSION 4 0.0000
835 HERPES ZOSTER 1 0.0000
836 LETHARGY 1 0.0000
837 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
838 BLADDER CANCER 1 0.0000
839 DISEASE PROGRESSION 2 0.0000
840 CATARACT 1 0.0000
841 SUICIDE ATTEMPT 1 0.0000
842 OEDEMA PERIPHERAL 2 0.0000
843 DISCOMFORT 1 0.0000
844 FEELING HOT 1 0.0000
845 GAIT DISTURBANCE 3 0.0000
846 HEPATIC ENZYME INCREASED 1 0.0000
847 INJECTION SITE REACTION 1 0.0000
848 ARTHRALGIA 6 0.0000
849 THERAPY INTERRUPTED 1 0.0000
850 CHRONIC KIDNEY DISEASE 1 0.0000
851 DIABETES MELLITUS 1 0.0000
852 FATIGUE 10 0.0000
853 SKIN EXFOLIATION 1 0.0000
854 CEREBROVASCULAR ACCIDENT 2 0.0000
855 MYALGIA 2 0.0000
856 BALANCE DISORDER 1 0.0000
857 PRODUCT STORAGE ERROR 1 0.0000
858 MUSCULOSKELETAL STIFFNESS 1 0.0000
859 SUICIDAL IDEATION 1 0.0000
860 PULMONARY EMBOLISM 1 0.0000
861 DRUG INTOLERANCE 1 0.0000
862 RHEUMATOID ARTHRITIS 1 0.0000
863 JOINT SWELLING 1 0.0000
864 EMOTIONAL DISTRESS 1 0.0000
865 DRY SKIN 1 0.0000
866 PRODUCT QUALITY ISSUE 1 0.0000
867 PAIN IN EXTREMITY 2 0.0000
868 URINARY TRACT INFECTION 1 0.0000
869 ALOPECIA 1 0.0000
870 CONSTIPATION 1 0.0000
871 INJECTION SITE PAIN 1 0.0000